← Open Payments lookup

DAVID MYERS: Open Payments

NPI 1598816696 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$631 in 16 payments from 11 companies in 2025. Trend: 2023 $909 · 2024 $641 · 2025 $631

Food & beverage: $631
CompanyPaymentsAmount
Gilead Sciences, Inc.1$125
Novo Nordisk Inc1$125
Eisai Inc.1$113
AstraZeneca Pharmaceuticals LP5$87
Lilly USA, LLC2$42
UCB, Inc.1$30
Aimmune Therapeutics, Inc.1$29
Lundbeck LLC1$27
Esperion Therapeutics, Inc.1$21
Boehringer Ingelheim Pharmaceuticals, Inc.1$17

Products named: Yeztugo, Ozempic, Leqembi, FARXIGA, MOUNJARO, BREZTRI, Nayzilam, ZENPEP.

Industry payments across LA — which companies pay providers there.